Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOPIRAMATE Cause Attention deficit/hyperactivity disorder? 34 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Attention deficit/hyperactivity disorder have been filed in association with TOPIRAMATE (Topiramate). This represents 0.1% of all adverse event reports for TOPIRAMATE.

34
Reports of Attention deficit/hyperactivity disorder with TOPIRAMATE
0.1%
of all TOPIRAMATE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Attention deficit/hyperactivity disorder From TOPIRAMATE?

Of the 34 reports, 1 (2.9%) required hospitalization.

Is Attention deficit/hyperactivity disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOPIRAMATE. However, 34 reports have been filed with the FAERS database.

What Other Side Effects Does TOPIRAMATE Cause?

Drug ineffective (5,553) Off label use (4,248) Product use in unapproved indication (2,173) Headache (1,997) Drug intolerance (1,820) Migraine (1,796) Nausea (1,691) Seizure (1,535) Paraesthesia (1,506) Dizziness (1,466)

What Other Drugs Cause Attention deficit/hyperactivity disorder?

METHYLPHENIDATE (127) VALPROATE (101) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (88) LAMOTRIGINE (88) SODIUM OXYBATE (85) PAROXETINE (68) FINASTERIDE (65) QUETIAPINE (62) ARIPIPRAZOLE (59) FLUOXETINE (56)

Which TOPIRAMATE Alternatives Have Lower Attention deficit/hyperactivity disorder Risk?

TOPIRAMATE vs TOPOTECAN TOPIRAMATE vs TOPOTECAN\TOPOTECAN TOPIRAMATE vs TOPROL TOPIRAMATE vs TOREMIFENE TOPIRAMATE vs TORIPALIMAB

Related Pages

TOPIRAMATE Full Profile All Attention deficit/hyperactivity disorder Reports All Drugs Causing Attention deficit/hyperactivity disorder TOPIRAMATE Demographics